Literature DB >> 31311335

Bipolar depression: the clinical characteristics and unmet needs of a complex disorder.

Roger S McIntyre1, Joseph R Calabrese2.   

Abstract

Objective: We reviewed important clinical aspects of bipolar depression, a progressive psychiatric condition that is commonly treated in primary care. Bipolar depression is associated with considerable burden of illness, high suicide risk, and greater morbidity and mortality than bipolar mania.
Methods: We identified articles relevant to our narrative review using a multistep search of the literature and applying terms that were relevant to bipolar depression or bipolar disorder.
Results: Bipolar depression accounts for the majority of time spent unwell for patients with bipolar disorder; high rates of morbidity and mortality arise from full symptomatic episodes and interepisode subsyndromal symptoms. Bipolar depression is an important contributor to long-term dysfunction for patients with bipolar disorder due to psychosocial impairment, loss of work productivity and high rates of substance abuse. Missed and delayed diagnosis is prevalent due to overlapping symptoms with unipolar depression and other diagnoses. Medical comorbidities (i.e. cardiovascular disease, hypertension, obesity, metabolic syndrome) and psychiatric comorbidities (i.e. anxiety disorder, personality disorder, eating disorder, attention-deficit/hyperactivity disorder) are common. Currently, only three treatments are FDA-approved for bipolar depression; monotherapy antidepressants are not a recommended treatment option. Conclusions: Bipolar disorder is common among primary care patients presenting with depression; it is often treated exclusively in primary care. Clinicians should be alert for symptoms of bipolar disorder in undiagnosed patients, know what symptoms probabilistically suggest bipolar versus unipolar depression, have expertise in providing ongoing treatment to diagnosed patients, and be knowledgeable about managing common medication-related side effects and comorbidities. Prompt and accurate diagnosis is critical.

Entities:  

Keywords:  Bipolar depression; atypical antipsychotics; bipolar disorder; comorbid conditions; misdiagnosis; mood stabilizers

Mesh:

Substances:

Year:  2019        PMID: 31311335     DOI: 10.1080/03007995.2019.1636017

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  17 in total

1.  Peripheral biomarkers to predict the diagnosis of bipolar disorder from major depressive disorder in adolescents.

Authors:  Xiaohui Wu; Zhiang Niu; Yuncheng Zhu; Yifan Shi; Hong Qiu; Wenjie Gu; Hongmei Liu; Jie Zhao; Lu Yang; Yun Wang; Tiebang Liu; Yong Xia; Yan Yang; Jun Chen; Yiru Fang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-08-25       Impact factor: 5.760

2.  The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.

Authors:  Roger S McIntyre; Martin Alda; Ross J Baldessarini; Michael Bauer; Michael Berk; Christoph U Correll; Andrea Fagiolini; Kostas Fountoulakis; Mark A Frye; Heinz Grunze; Lars V Kessing; David J Miklowitz; Gordon Parker; Robert M Post; Alan C Swann; Trisha Suppes; Eduard Vieta; Allan Young; Mario Maj
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

3.  Using decision-analysis modelling to estimate the economic impact of the identification of unrecognised bipolar disorder in primary care: the untapped potential of screening.

Authors:  Jiri Benacek; Nayra A Martin-Key; Benedetta Spadaro; Jakub Tomasik; Sabine Bahn
Journal:  Int J Bipolar Disord       Date:  2022-06-10

4.  Toward low-risk approaches to prevent bipolar disorder in at-risk youth.

Authors:  Danielle A Goldman; Hilary P Blumberg
Journal:  Bipolar Disord       Date:  2022-02-24       Impact factor: 5.345

Review 5.  Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.

Authors:  Ellen Doney; Alice Cadoret; Laurence Dion-Albert; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2021-05-17       Impact factor: 3.698

Review 6.  S100A6 and Its Brain Ligands in Neurodegenerative Disorders.

Authors:  Anna Filipek; Wiesława Leśniak
Journal:  Int J Mol Sci       Date:  2020-06-01       Impact factor: 5.923

7.  Emotional regulation neural circuitry abnormalities in adult bipolar disorder: dissociating effects of long-term depression history from relationships with present symptoms.

Authors:  Michele A Bertocci; Jeffrey Bergman; Joao Paulo Lima Santos; Satish Iyengar; Lisa Bonar; Mary Kay Gill; Halimah Abdul-Waalee; Genna Bebko; Richelle Stiffler; Jeanette Lockovich; Haris Aslam; Cecile Ladouceur; John Merranko; Rasim Diler; Boris Birmaher; Amelia Versace; Mary L Phillips
Journal:  Transl Psychiatry       Date:  2020-11-02       Impact factor: 6.222

8.  Meta-analysis of sleep deprivation in the acute treatment of bipolar depression.

Authors:  John F Gottlieb; Namni Goel; Shenghao Chen; Michael A Young
Journal:  Acta Psychiatr Scand       Date:  2020-12-26       Impact factor: 6.392

Review 9.  Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters.

Authors:  Teresa Iannaccone; Carmine Sellitto; Valentina Manzo; Francesca Colucci; Valentina Giudice; Berenice Stefanelli; Antonio Iuliano; Giulio Corrivetti; Amelia Filippelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-01

10.  Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.

Authors:  Xiaoli Niu; Syvart Dennen; Carole Dembek; Kimberly Laubmeier; Yanmei Liu; Phani Veeranki; Michael Tocco; G Rhys Williams
Journal:  Curr Ther Res Clin Exp       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.